Ligand · VQJ
VQJ · 3,4-difluoro-N-({1-[(2R)-4-(hydroxyamino)-4-oxo-1-(quinolin-7-yl)butan-2-yl]-1H-1,2,3-triazol-4-yl}methyl)benzamide
VQJ, 3,4-difluoro-N-({1-[(2R)-4-(hydroxyamino)-4-oxo-1-(quinolin-7-yl)butan-2-yl]-1H-1,2,3-triazol-4-yl}methyl)benzamide (C23 H20 F2 N6 O3, 466.4 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every…
- Component
- VQJ
- Formula
- C23 H20 F2 N6 O3
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
VQJ in 2 structures; the first of them:
- 7K1F · Crystal structure of human insulin degrading enzyme (IDE) in complex with compound… · VQJ A1102 · binds HIS108, GLU111, HIS112, PHE115, LEU116, SER128, SER132, SER138 and 12 more
- 7K1F · Crystal structure of human insulin degrading enzyme (ide) in complex with compound… · VQJ A1102 · binds HIS108, GLU111, HIS112, PHE115, LEU116, SER128, ASN139, ALA140 and 8 more
Residues it binds most
GLU 4, SER 4, PHE 4, HIS 4, THR 4, ALA 4, ARG 4, ASN 4, LEU 4, TYR 4 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.